Skip to main content
Top
Published in: Rheumatology International 2/2018

01-02-2018 | Comorbidities

Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy

Authors: Helen V. Udachkina, Diana S. Novikova, Tatiana V. Popkova, Irina G. Kirillova, Evgenia I. Markelova, Elena L. Luchikhina, Galina V. Lukina, Valentin E. Sinitsyn, Dmitry E. Karateev, Eugeniy L. Nasonov

Published in: Rheumatology International | Issue 2/2018

Login to get access

Abstract

Accelerated coronary atherosclerosis is common in patients with rheumatoid arthritis (RA). To examine coronary artery calcification (CAC) frequency and severity, its correlation with traditional risk factors (TRF) of cardiovascular diseases (CVD) and inflammatory markers in patients with early RA prior to anti-rheumatic therapy. RA adult patients (ACR/EULAR criteria, 2010, duration ≤ 12 months, without prior administration of disease-modifying anti-rheumatic drugs, glucocorticoids) underwent 32-row scanning for CAC scoring. Agatston, volume and mass calcium scores were calculated. Additionally, we used calculators on the website of the Multi-Ethnic Study of Atherosclerosis. 74 RA patients (women n = 54 (73%), median age 56 years, median RA duration 6 months) with moderate/high RA activity (median DAS28 [ESR] 5.4) were enrolled within the framework of the observational study. Most of the patients had multiple TRFs of CVD and subclinical organ damage. CAC has been detected in 34 (46%) early RA patients. Calcification severity was significantly higher in men and in patients with ischemic heart disease (IHD). In patients younger than 45 years (n = 16) CAC was not detected. Among patients older than 45 years (n = 58), the frequency of CAC was 59%: asymptomatic patients—n = 46 (48%), IHD patients—n = 12 (100%). Among asymptomatic patients the presence of CAC associated with a significantly higher frequency of arterial hypertension (1.6 fold) compared with cases without CAC. Coronary age in asymptomatic patients with CAC and IHD patients was significantly greater than their actual age. More than half of early RA patients older 45 years had CAC. The presence and severity of CAC correlated positively with TRFs, but not with lipid levels and RA activity.
Literature
1.
go back to reference Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608–1612CrossRefPubMedPubMedCentral Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608–1612CrossRefPubMedPubMedCentral
2.
go back to reference Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449CrossRefPubMed Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449CrossRefPubMed
3.
go back to reference del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745CrossRefPubMed del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745CrossRefPubMed
4.
go back to reference Franklin J, Farragher TM, Lunt M, Camacho EM, Bunn D, Marshall T, Symmons DP (2010) Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis. Ann Rheum Dis 69:1660–1664CrossRefPubMedPubMedCentral Franklin J, Farragher TM, Lunt M, Camacho EM, Bunn D, Marshall T, Symmons DP (2010) Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis. Ann Rheum Dis 69:1660–1664CrossRefPubMedPubMedCentral
5.
go back to reference Södergren A, Karp K, Boman K, Eriksson C, Lundström E, Smedby T, Söderlund L, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2010) Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther 12:R158CrossRefPubMedPubMedCentral Södergren A, Karp K, Boman K, Eriksson C, Lundström E, Smedby T, Söderlund L, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2010) Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther 12:R158CrossRefPubMedPubMedCentral
6.
go back to reference Naz SM, Farragher TM, Bunn DK, Symmons DPM, Bruce IN (2008) The influence of age at symptom onset and length of follow up on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum 58:985–989CrossRefPubMedPubMedCentral Naz SM, Farragher TM, Bunn DK, Symmons DPM, Bruce IN (2008) The influence of age at symptom onset and length of follow up on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum 58:985–989CrossRefPubMedPubMedCentral
7.
go back to reference Holmqvist ME, Wedrén S, Jacobsson LT, Klareskog L, Nyberg F, Rantapää-Dahlqvist S, Alfredsson L, Askling J (2010) Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 268:578–585CrossRefPubMed Holmqvist ME, Wedrén S, Jacobsson LT, Klareskog L, Nyberg F, Rantapää-Dahlqvist S, Alfredsson L, Askling J (2010) Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 268:578–585CrossRefPubMed
8.
go back to reference Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Généreux P (2014) Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol 63:1703–1714CrossRefPubMed Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Généreux P (2014) Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol 63:1703–1714CrossRefPubMed
9.
go back to reference Yiu KH, Mok MY, Wang S, Ooi GC, Khong PL, Lau CS, Tse HF (2012) Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 30:345–350PubMed Yiu KH, Mok MY, Wang S, Ooi GC, Khong PL, Lau CS, Tse HF (2012) Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 30:345–350PubMed
10.
go back to reference Giles JT, Szklo M, Post W, Petri M, Blumenthal RS, Lam G, Gelber AC, Detrano R, Scott WW Jr, Kronmal RA, Bathon JM (2009) Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther 11:R36CrossRefPubMedPubMedCentral Giles JT, Szklo M, Post W, Petri M, Blumenthal RS, Lam G, Gelber AC, Detrano R, Scott WW Jr, Kronmal RA, Bathon JM (2009) Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther 11:R36CrossRefPubMedPubMedCentral
11.
go back to reference Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM (2005) Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52:3045–3053CrossRefPubMed Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM (2005) Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52:3045–3053CrossRefPubMed
12.
go back to reference Kao AH, Krishnaswami S, Cunningham A, Edmundowicz D, Morel PA, Kuller LH, Wasko MC (2008) Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis. J Rheumatol 35:61–69PubMed Kao AH, Krishnaswami S, Cunningham A, Edmundowicz D, Morel PA, Kuller LH, Wasko MC (2008) Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis. J Rheumatol 35:61–69PubMed
13.
go back to reference Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C et al (2010) The 2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis. Arthritis Rheum. doi:10.1136/ard.2010.130310 PubMedCentral Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C et al (2010) The 2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis. Arthritis Rheum. doi:10.​1136/​ard.​2010.​130310 PubMedCentral
14.
go back to reference Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. JACC 15:827–832CrossRefPubMed Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. JACC 15:827–832CrossRefPubMed
15.
go back to reference Touboul PJ, Hennerici MG, Meairs S et al (2007) Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75–80CrossRefPubMed Touboul PJ, Hennerici MG, Meairs S et al (2007) Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75–80CrossRefPubMed
16.
go back to reference The Task Force on diabetes (2013) pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD): guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed. Eur Heart J 34:3035–3087CrossRef The Task Force on diabetes (2013) pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD): guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed. Eur Heart J 34:3035–3087CrossRef
17.
go back to reference The task force on the management of stable coronary artery disease of the European Society of Cardiology (2013) ESC guidelines on the management of stable coronary artery disease. Reference Eur Heart J 34:2949–3003CrossRef The task force on the management of stable coronary artery disease of the European Society of Cardiology (2013) ESC guidelines on the management of stable coronary artery disease. Reference Eur Heart J 34:2949–3003CrossRef
18.
go back to reference Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž (2016) The Task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and european atherosclerosis society (EAS) ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 37:2999–3058CrossRefPubMed Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž (2016) The Task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and european atherosclerosis society (EAS) ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 37:2999–3058CrossRefPubMed
19.
go back to reference Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K (1996) Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Circulation 94:1175–1192CrossRefPubMed Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K (1996) Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Circulation 94:1175–1192CrossRefPubMed
21.
go back to reference Kalra SS, Shanahan CM (2012) Vascular calcification and hypertension: cause and effect. Ann Med 44(Suppl 1):S85–S92CrossRefPubMed Kalra SS, Shanahan CM (2012) Vascular calcification and hypertension: cause and effect. Ann Med 44(Suppl 1):S85–S92CrossRefPubMed
22.
go back to reference Glagov S, Vito R, Giddens DP, Zarins CK (1992) Micro-architecture and composition of artery walls: relationships to location, diameter and the distribution of mechanical stress. J Hypertens 10(suppl 6):S101–S104 Glagov S, Vito R, Giddens DP, Zarins CK (1992) Micro-architecture and composition of artery walls: relationships to location, diameter and the distribution of mechanical stress. J Hypertens 10(suppl 6):S101–S104
23.
go back to reference Chironi G, Gariepy J, Denarie N, Balice M, Megnien JL, Levenson J, Simon A (2003) Influence of hypertension on early carotid artery remodeling. Arterioscler Thromb Vasc Biol 23:1460–1464CrossRefPubMed Chironi G, Gariepy J, Denarie N, Balice M, Megnien JL, Levenson J, Simon A (2003) Influence of hypertension on early carotid artery remodeling. Arterioscler Thromb Vasc Biol 23:1460–1464CrossRefPubMed
24.
go back to reference Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:482–487CrossRefPubMedPubMedCentral Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:482–487CrossRefPubMedPubMedCentral
25.
go back to reference Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449CrossRefPubMed Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437–449CrossRefPubMed
Metadata
Title
Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy
Authors
Helen V. Udachkina
Diana S. Novikova
Tatiana V. Popkova
Irina G. Kirillova
Evgenia I. Markelova
Elena L. Luchikhina
Galina V. Lukina
Valentin E. Sinitsyn
Dmitry E. Karateev
Eugeniy L. Nasonov
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3860-9

Other articles of this Issue 2/2018

Rheumatology International 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine